Kodiak sciences inc. (KOD)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Sep'17
Operating expenses
Research and development

20,170

12,830

10,115

8,838

5,723

6,851

4,709

3,591

3,642

3

General and administrative

5,553

3,354

2,617

2,976

2,737

2,506

1,671

1,499

1,905

0

Total operating expenses

25,723

16,184

12,732

11,814

8,460

9,357

6,380

5,090

5,547

3

Loss from operations

-25,723

-16,184

-12,732

-11,814

-8,460

-9,357

-6,380

-5,090

-5,547

-3

Interest income

1,208

321

354

431

462

493

0

76

48

-

Interest expense

7

0

2

2

4

190

1,982

1,877

1,470

0

Other income (expense), net

130

247

0

0

18

-129

-2,090

-518

-1,951

-0

Net loss

-24,392

-15,616

-12,380

-11,385

-7,984

-14,662

-10,452

-7,409

-8,920

-4

Net loss per common share, basic and diluted

-0.54

-0.40

-0.33

-0.31

-0.21

0.68

-1.33

-0.96

-1.16

-0.61

Weighted-average common shares outstanding used in computing net loss per common share, basic and diluted

44,824

39,541

37,330

37,294

37,248

36,613

7,851

7,757

7,684

7,549

Other comprehensive income
Change in unrealized gains related to available-for-sale debt securities, net of tax

479

-9

7

6

6

-

0

0

0

-

Total other comprehensive income

479

-9

7

6

6

-

0

0

0

-

Comprehensive loss

-23,913

-15,625

-12,373

-11,379

-7,978

-14,662

-10,452

-7,409

-8,920

-